LEEDS, England, May 20 /PRNewswire/ -- Teva UK Limited has welcomed the election of Kim Innes, Director of the company's generics business, as Chairman of the British Generic Manufacturers Association (BGMA) for a two-year term. During her spell in office, she will divide her time between Association duties and her role as Director, Teva Generics. John Beighton, Managing Director of Teva UK Limited, said he was delighted on both a personal and company level at Kim's election: "Kim is an outstanding personality in the generics world and I'm delighted that she has been elected to lead our industry. Her vision, energy and knowledge of the industry will stand her in good stead, and I'm confident she will be an effective and vocal ambassador for the Association's members on behalf of the generics industry and its customers."

Kim has worked in the generics industry since 1991 and was appointed to head Teva's generics business unit in the UK in 2006. John said: "We have a very strong management team in our generics business supporting Kim in her Teva Generics role, so she can devote some time to building on the BGMA's already excellent work in supporting the industry's call for a fair deal for generics. Meanwhile I look forward, as a member company of the BGMA, to working with Kim on telling the great story that the BGMA and its members have to offer."

Notes to editors:

Teva UK Limited is one of the UK's leading pharmaceutical manufacturers, with a presence in the generics, branded respiratory and hospitals markets. With over 500 product lines, it has the widest range of any UK generic pharmaceutical company and has a number of innovative respiratory products including the Qvar(R) (beclometasone dipropionate) CFC-free inhaler.

Media enquiries: Paul Williams, Communications Manager, +44(0)113-201-3907